![Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com](https://media.snacksafely.com/wp-content/uploads/2019/07/Digihaler-1068x559.jpg)
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
![Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel](https://img.medicalexpo.com/images_me/projects/images-g/teva-s-proair-digihaler-fda-approved-to-monitor-asthma-copd-treatment-26785-13464157.jpg)
Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel
![Teva Pharmaceutical touts real-world data on ProAir Digihaler for asthma (NYSE:TEVA) | Seeking Alpha Teva Pharmaceutical touts real-world data on ProAir Digihaler for asthma (NYSE:TEVA) | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304488209/image_1304488209.jpg?io=getty-c-crop-4-3)
Teva Pharmaceutical touts real-world data on ProAir Digihaler for asthma (NYSE:TEVA) | Seeking Alpha
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
![Teva Announces FDA Approval of 2 New Respiclick Maintenance Inhalers - Drug Discovery and Development Teva Announces FDA Approval of 2 New Respiclick Maintenance Inhalers - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/shutterstock_inhaler_2.jpg)
Teva Announces FDA Approval of 2 New Respiclick Maintenance Inhalers - Drug Discovery and Development
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder](https://mms.businesswire.com/media/20200921005170/en/819864/4/Interactive_Media_Placeholder_webready.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
![Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma](https://mma.prnewswire.com/media/1306006/Teva_Canada_Teva_Canada_announces_availability_of_Aermony_RespiC.jpg?p=twitter)
Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma
![Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire](https://mms.businesswire.com/media/20201005005212/en/826961/5/AermonyRespiClick_ENG.jpg?download=1)
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire
Teva Pharmaceutical Industries Ltd. - Did you know that 4.5 to 5.9 million Americans suffer from a severe form of #asthma called #eosinophilic asthma? Learn more about the condition in this infographic! #WorldAsthmaDay | Facebook
![Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/Inhaler.png)